Objective: To explore the short-term effect of radiofrequency ablation (RFA) combined with arterial embolization in treating patients with primary liver cancer.
Methods: Thirty patients with primary liver cancer received the combined treatment and the pre- and post-operative alpha-fetoprotein (AFP) levels, imaging features, and liver function were investigated along with observation of the incidence of complications to evaluate the therapeutic effects.
Results: The post-operative AFP positivity and the tumor density were significantly reduced in these patients, and their one-year survival rate reached 96.7% with only minor complications observed.
Conclusion: RFA combined with arterial embolization is effective for primary liver cancer.